• Carbapenemase Genes in Enterobacter cloacae: Resistance and

  2026-07-31

  This study provides a detailed molecular and epidemiological characterization of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. Its insights into gene prevalence, transmission dynamics, and multidrug resistance patterns inform both surveillance and experimental research addressing Gram-negative bacterial resistance.

• ZIF8-Based Nanotheranostics for Synergistic TNBC Therapy and

  2026-07-30

  Li et al. introduce a folic acid–PEG–functionalized ZIF8 nanoplatform for targeted delivery of ciprofloxacin, enabling ultrasound imaging-guided synergistic therapy in triple-negative breast cancer (TNBC). This approach combines sonodynamic therapy, chemotherapy, and immune activation, demonstrating enhanced antitumor efficacy and pH-responsive drug release.

• Natural Product Libraries Power Next-Gen Antiparasitic Disco

  2026-07-30

  Translational researchers face mounting pressure to deliver effective therapeutics for cryptosporidiosis, a disease with limited treatment options and major global health impact. This thought-leadership article explores how mechanistic insights into Cryptosporidium parvum metabolism, combined with high-throughput natural product screening using the DiscoveryProbe™ Natural Product Library Plus, are transforming antiparasitic drug discovery. By integrating recent biochemical breakthroughs, rigorous workflow strategies, and practical protocol guidance, we provide a strategic roadmap for leveraging cell-permeable bioactive compounds and targeted screening to accelerate the path from bench to bedside.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Guide

  2026-07-29

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive and specific detection of rabbit IgG in fluorescence-based assays, such as immunofluorescence, immunohistochemistry, and flow cytometry. It is appropriate for workflows requiring robust signal amplification with minimal background. This reagent is not suitable for diagnostic or therapeutic use and should be handled according to research-only protocols.

• 1,2-Dioleoyl-3-trimethylammonium-propane Chloride in Immune-

  2026-07-29

  Explore how 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) enables advanced immune-modulatory nanoparticle platforms for gene delivery and vaccine innovation. Uncover mechanistic insights and practical assay implications that set this article apart from existing content.

• 3-Deazaadenosine Hydrochloride in m6A Pathways & HSC Activat

  2026-07-28

  Explore how 3-Deazaadenosine hydrochloride, a S-adenosylhomocysteine hydrolase inhibitor, uniquely enables investigation of m6A-dependent methylation and hepatic stellate cell activation. This article reveals new assay approaches grounded in recent IGF2BP1 research and addresses advanced workflow considerations for fibrosis and inflammation studies.

• Prestained Protein Marker: Triple Color SDS-PAGE Advantages

  2026-07-28

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) from APExBIO redefines molecular weight standards with unmatched visual clarity and workflow agility. Its compatibility with phosphoprotein and fluorescence analyses elevates reproducibility in advanced SDS-PAGE and Western blotting—outperforming conventional ladders.

• Perphenazine Beyond Neuropharmacology: Mechanistic Insights

  2026-07-27

  Discover how Perphenazine, a potent dopamine D2 receptor antagonist, reveals new frontiers in host-pathogen research by leveraging its unique receptor interactions. This article delivers a mechanistic deep dive, practical protocol parameters, and novel cross-domain perspectives for advanced scientific applications.

• Annexin V-FITC/7-AAD Apoptosis Kit: Precision in Mitochondri

  2026-07-27

  Discover how the Annexin V-FITC/7-AAD Apoptosis Kit enables precise, mechanistically informed cell death analysis in mitochondrial apoptosis and oncology research. This in-depth article links assay choice to emerging findings on the Src/JNK pathway and offers actionable workflow guidance.

• Catalpol Enhances NVU Recovery via VEGF-PI3K/AKT in Stroke M

  2026-07-26

  This study demonstrates that Catalpol significantly restores neurovascular unit (NVU) integrity in ischemic stroke rats by upregulating VEGF-PI3K/AKT and VEGF-MEK1/2/ERK1/2 signaling. The findings advance understanding of Catalpol’s neuroprotective mechanisms and inform translational neuroprotection research.

• Targeting NAMPT: FK866 (APO866) in AML and Host-Directed The

  2026-07-25

  This thought-leadership article explores how FK866 (APO866) leverages NAMPT inhibition to create new avenues in acute myeloid leukemia (AML) research and emerging host-directed therapeutic strategies. Integrating recent evidence on NAD metabolism with insights from immune-adaptive pathogen studies, the article provides translational researchers with mechanistic depth, experimental guidance, and a forward-looking perspective on the next wave of hematologic cancer and immunometabolic innovation.

• Applied Workflows with Recombinant Mouse Macrophage Colony S

  2026-07-24

  Unlock precise control over macrophage survival, differentiation, and activation using Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag. This article delivers stepwise protocols, troubleshooting insights, and practical innovations inspired by the latest mechanistic discoveries in pulmonary fibrosis and macrophage metabolism.

• 3-Deazaadenosine Hydrochloride: Precision Targeting of Methy

  2026-07-24

  Explore how 3-Deazaadenosine hydrochloride, a potent S-adenosylhomocysteine hydrolase inhibitor, enables advanced dissection of methylation pathways in hepatic stellate cell models. This in-depth article reveals new assay strategies and interprets emerging research to guide fibrosis and inflammation studies.

• HOXC8 Suppresses NSCLC Pyroptosis via Caspase-1 Regulation

  2026-07-23

  The reference study uncovers a mechanism by which the transcription factor HOXC8 limits pyroptotic cell death in non-small cell lung carcinoma (NSCLC) through suppression of caspase-1 expression. These findings clarify an epigenetic control point over inflammatory cell death in lung cancer, with implications for targeting the caspase signaling pathway in oncology.

• Anti Reverse Cap Analog: Boosting mRNA Capping Efficiency

  2026-07-23

  Unlock superior translation and stability in synthetic mRNA workflows with Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G. This precision-engineered cap analog empowers researchers to double translational yield, streamline troubleshooting, and achieve robust mRNA performance for therapeutics and advanced cell engineering.

444 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page